Hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy is a condition in which the heart muscle becomes thicker than normal. In most people the thickening is in the wall between the two lower chambers, and it can block the flow of blood out of the heart. Most people with the form that has no other cause have a normal life expectancy, but some develop an abnormal heart rhythm that may be life-threatening and a small number develop heart failure. The risk of sudden death is higher than usual, although it remains uncommon. In the United States the label of the medicine mavacamten gives symptomatic obstructive disease as its indication.

Also called HCM

  • Condition
  • In this atlas

Overview

Technical summary

MeSH descriptor D002312 (Cardiomyopathy, Hypertrophic). The MeSH scope note describes a form of cardiac muscle disease with left or right ventricular hypertrophy, frequent uneven involvement of the heart septum and normal or reduced left ventricular volume. The MedlinePlus Genetics page describes the nonsyndromic form, which is not explained by another cause and does not affect other parts of the body, so its statements on life expectancy and sudden death may not fit every person with the condition. A 2024 US guideline covers management of the condition; only its abstract was read for this atlas.

Burden

No burden claims are published.

Claims and evidence

Context People with cardiomyopathy, as described in MeSH, MedlinePlus, MedlinePlus Genetics and NHLBI reference pages

Recipient
Recipient not specified
Population
People with cardiomyopathy in general. The pages are written for the public or as a vocabulary and give no study population. They describe adults and also say that newborns and children can have cardiomyopathy. The MedlinePlus Genetics pages describe the nonsyndromic forms, which are not explained by other causes and do not affect other parts of the body.
Care setting
General health information for the public; no care setting is stated
Geography
United States (pages of US government agencies); the MeSH vocabulary is international
Life stage
Not limited by age. NHLBI says people of any age can have cardiomyopathy, including newborns and children, and names peripartum cardiomyopathy as a form that affects some women around pregnancy.
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (descriptive statement)
Eligibility: inclusion criteria not stated; exclusion criteria not stated
Included
None stated
Excluded
None stated
  • Description Evidence stage unknown Certainty not assessed

    The MeSH scope note describes hypertrophic cardiomyopathy as a form of heart muscle disease with thickening of the left or right ventricle, frequent uneven involvement of the heart septum and normal or reduced left ventricular volume. MedlinePlus Genetics describes it, in its nonsyndromic form, as thickening of the heart muscle, most often in the wall between the lower chambers, which can obstruct the flow of blood out of the heart. It says most people with this form have a normal life expectancy, that some develop an abnormal heart rhythm that may be life-threatening, that a small number develop heart failure, and that the risk of sudden death is increased although uncommon.

    Applies to Recipient not specified People with cardiomyopathy, as described in MeSH, MedlinePlus, MedlinePlus Genetics and NHLBI reference pages

    Certainty method
    Not assessed
    Limitations
    Vocabulary and patient-education pages from US government sources. The MedlinePlus Genetics page describes the nonsyndromic form, which is not explained by another cause and does not affect other parts of the body, so it may not describe every person with the condition. The pages give no study, no size of risk and no population beyond the general public.
    Last checked
    2026-10-30
    Next evidence check due
    Not scheduled
    Sources and citations (8)
    1. Supports MeSH scope note for descriptor D002312 (Cardiomyopathy, Hypertrophic)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0003464 of descriptor D002312, fetched 2026-10-30. The scope note is on this concept record, not on the descriptor record. · MeSH: M0003464

      Locator
      scopeNote.@value
      How it applies
      MeSH scope note of the descriptor Cardiomyopathy, Hypertrophic.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      e2dfd8316c24d06935f24c456e33a57491edce6e41d54c3730008928e88c950e
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. This copy was fetched on 2026-10-30 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    2. Supports Nonsyndromic hypertrophic cardiomyopathy (MedlinePlus Genetics)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated June 16, 2026. The address uses the older name familial hypertrophic cardiomyopathy; the page title is Nonsyndromic hypertrophic cardiomyopathy.

      Locator
      Description, para 1, sentence 1
      How it applies
      What the condition is.
      Retrieved
      Source effective date
      2026-06-16
      Source state
      Current
      Version fingerprint
      55387d73362d9a3ae21a7fac384499277ea4183402dcc10dcd9e91c51c89ca45
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
    3. Supports Nonsyndromic hypertrophic cardiomyopathy (MedlinePlus Genetics)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated June 16, 2026. The address uses the older name familial hypertrophic cardiomyopathy; the page title is Nonsyndromic hypertrophic cardiomyopathy.

      Locator
      Description, para 2, sentence 2
      How it applies
      Where the thickening usually occurs.
      Retrieved
      Source effective date
      2026-06-16
      Source state
      Current
      Version fingerprint
      55387d73362d9a3ae21a7fac384499277ea4183402dcc10dcd9e91c51c89ca45
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
    4. Supports Nonsyndromic hypertrophic cardiomyopathy (MedlinePlus Genetics)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated June 16, 2026. The address uses the older name familial hypertrophic cardiomyopathy; the page title is Nonsyndromic hypertrophic cardiomyopathy.

      Locator
      Description, para 2, sentence 3
      How it applies
      Obstruction of blood flow.
      Retrieved
      Source effective date
      2026-06-16
      Source state
      Current
      Version fingerprint
      55387d73362d9a3ae21a7fac384499277ea4183402dcc10dcd9e91c51c89ca45
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
    5. Supports Nonsyndromic hypertrophic cardiomyopathy (MedlinePlus Genetics)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated June 16, 2026. The address uses the older name familial hypertrophic cardiomyopathy; the page title is Nonsyndromic hypertrophic cardiomyopathy.

      Locator
      Description, para 4, sentence 1
      How it applies
      Life expectancy of most people with the nonsyndromic form.
      Retrieved
      Source effective date
      2026-06-16
      Source state
      Current
      Version fingerprint
      55387d73362d9a3ae21a7fac384499277ea4183402dcc10dcd9e91c51c89ca45
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
    6. Supports Nonsyndromic hypertrophic cardiomyopathy (MedlinePlus Genetics)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated June 16, 2026. The address uses the older name familial hypertrophic cardiomyopathy; the page title is Nonsyndromic hypertrophic cardiomyopathy.

      Locator
      Description, para 4, sentence 2
      How it applies
      Abnormal heart rhythm.
      Retrieved
      Source effective date
      2026-06-16
      Source state
      Current
      Version fingerprint
      55387d73362d9a3ae21a7fac384499277ea4183402dcc10dcd9e91c51c89ca45
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
    7. Supports Nonsyndromic hypertrophic cardiomyopathy (MedlinePlus Genetics)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated June 16, 2026. The address uses the older name familial hypertrophic cardiomyopathy; the page title is Nonsyndromic hypertrophic cardiomyopathy.

      Locator
      Description, para 4, sentence 3
      How it applies
      Heart failure.
      Retrieved
      Source effective date
      2026-06-16
      Source state
      Current
      Version fingerprint
      55387d73362d9a3ae21a7fac384499277ea4183402dcc10dcd9e91c51c89ca45
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
    8. Supports Nonsyndromic hypertrophic cardiomyopathy (MedlinePlus Genetics)

      Webpage · U.S. National Library of Medicine (MedlinePlus) · Edition Page fetched 2026-10-30. The page says it was last updated June 16, 2026. The address uses the older name familial hypertrophic cardiomyopathy; the page title is Nonsyndromic hypertrophic cardiomyopathy.

      Locator
      Description, para 4, sentence 4
      How it applies
      Sudden death risk.
      Retrieved
      Source effective date
      2026-06-16
      Source state
      Current
      Version fingerprint
      55387d73362d9a3ae21a7fac384499277ea4183402dcc10dcd9e91c51c89ca45
      Reuse basis
      MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Registry records

Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry trials 32

Record details

Record id
cardio:hypertrophic-cardiomyopathy
Content hash
d549816b879e18c22f00eeb14a946dbcec40f0d560d9b1e45cc748d1b99818be